Enterprise record
Alpha ID: alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2Version: public-1
22 published Claims6 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 3, 2026
Supports 3 claims
- Legal Name: Monopar Therapeutics · Claim reviewed: Oct 3, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 3, 2026
- Published Fact: US · Claim reviewed: Oct 3, 2026
Monopar Therapeutics DEF 14A 2025-04-30
sec proxy · Source published: Apr 30, 2025 · Retrieved: Apr 28, 2026
Supports 6 claims
- Leadership Role: Arthur J. Klausner, MBA: Director, Audit; Compensation; Nominating and Governance · Chair · Claim reviewed: Oct 3, 2026
- Leadership Role: Chandler D. Robinson, MD MBA MSc: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Christopher M. Starr, PhD: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Kim R. Tsuchimoto: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Lavina Talukdar, CFA: Director, Audit; Compensation; Nominating and Governance · Claim reviewed: Oct 3, 2026
- Leadership Role: Raymond W. Anderson, MBA MS: Director, Audit · Chair; Compensation · Chair; Nominating and Governance · Claim reviewed: Oct 3, 2026
MNPR DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Chandler D. Robinson: CEO, Co-Founder and Director · Claim reviewed: Oct 3, 2026
Audit
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: Audit: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA · Claim reviewed: Oct 3, 2026
- Committee Appointment: Raymond W. Anderson, MBA MS: chair, Audit · Claim reviewed: Oct 3, 2026
- Committee Appointment: Arthur J. Klausner, MBA: member, Audit · Claim reviewed: Oct 3, 2026
- Committee Appointment: Lavina Talukdar, CFA: member, Audit · Claim reviewed: Oct 3, 2026
Compensation
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: Compensation: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA · Claim reviewed: Oct 3, 2026
- Committee Appointment: Raymond W. Anderson, MBA MS: chair, Compensation · Claim reviewed: Oct 3, 2026
- Committee Appointment: Arthur J. Klausner, MBA: member, Compensation · Claim reviewed: Oct 3, 2026
- Committee Appointment: Lavina Talukdar, CFA: member, Compensation · Claim reviewed: Oct 3, 2026
Nominating and Governance
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: Nominating and Governance: Chair Arthur J. Klausner, MBA; Members Arthur J. Klausner, MBA (Chair); Lavina Talukdar, CFA; Raymond W. Anderson, MBA MS · Claim reviewed: Oct 3, 2026
- Committee Appointment: Arthur J. Klausner, MBA: chair, Nominating and Governance · Claim reviewed: Oct 3, 2026
- Committee Appointment: Lavina Talukdar, CFA: member, Nominating and Governance · Claim reviewed: Oct 3, 2026
- Committee Appointment: Raymond W. Anderson, MBA MS: member, Nominating and Governance · Claim reviewed: Oct 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed